Trials / Conditions / Major Depressive Episode

Major Depressive Episode

67 registered clinical trials studyying Major Depressive Episode — 17 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Signature Response to Light Therapy in Unipolar and Bipolar Major Depressive Episode (MDE) NCT07462637	Assistance Publique - Hôpitaux de Paris	N/A
Recruiting	Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD) NCT07111390	NYU Langone Health	N/A
Recruiting	Personalized Ultrasonic Brain Stimulation for Depression (R61) NCT06902298	Brian Mickey	Phase 1 / Phase 2
Recruiting	The Impact of Coach-guided Risk Communication on the Risk of Major Depression NCT06619366	Dalhousie University	N/A
Recruiting	Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents NCT06523439	University of Texas at Austin	N/A
Recruiting	Digital Interventions for Adults with Treatment-Resistant Depression: a Pilot Study NCT06732089	Unity Health Toronto	—
Recruiting	Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients NCT06508710	Assistance Publique - Hôpitaux de Paris	Phase 3
Recruiting	At-Home tDCS as Maintenance Therapy NCT07269964	Technical University of Munich	N/A
Completed	A Text Messaging Intervention to Reduce Perinatal Depression Risk NCT06117397	University of Massachusetts, Worcester	N/A
Terminated	SAINT for MDD in an Inpatient Setting Follow-on NCT06462820	Magnus Medical	Phase 2 / Phase 3
Terminated	The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition NCT03693105	Magnus Medical	Phase 2 / Phase 3
Recruiting	Metabolomics During ElectroConvulsivoTherapy NCT05973643	Hôpital le Vinatier	N/A
Recruiting	Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics NCT04130958	Massachusetts General Hospital	N/A
Recruiting	Presynaptic Imaging in Major Depressive Episodes After COVID-19 NCT06086366	Centre for Addiction and Mental Health	—
Completed	The RAFT ECT Study NCT05402657	The George Institute	N/A
Recruiting	Cohort of Patients Suffering From Major Depressive Episode With Evaluation of Sleep, Circadian Rhythms and Psy NCT05866991	Assistance Publique - Hôpitaux de Paris	—
Completed	Microglial Activation in Inflammatory Bowel Disease NCT03487926	Centre for Addiction and Mental Health	—
Completed	Personalized Repetitive Transcranial Magnetic Stimulation Treatment for Major Depressive Episode NCT05465928	Jiangsu Province Nanjing Brain Hospital	N/A
Active Not Recruiting	Personalized Ultrasonic Brain Stimulation for Depression NCT05301036	University of Utah	Phase 1 / Phase 2
Completed	Mobile Observation Of Depression NCT05815459	Emteq Ltd	—
Terminated	Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression NCT05063604	Hospital Universitari de Bellvitge	Phase 2
Unknown	Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) Treatment for Major Depressive NCT05498441	Jiangsu Province Nanjing Brain Hospital	N/A
Completed	Affective Touch, Hedonia and Suicidal Behavior NCT05182827	University Hospital, Montpellier	N/A
Unknown	Left vs. Right Non-Inferiority Trial NCT04999553	University of British Columbia	N/A
Recruiting	Patient-oriented Randomized Pragmatic Feasibility Trial with RTMS in Depression and Anxiety NCT05028738	University of British Columbia	N/A
Recruiting	Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive E NCT03646058	Centre Hospitalier Universitaire de Nīmes	Phase 3
Completed	Ketamine As an Adjunctive Therapy for Major Depression (2) NCT04939649	University of Dublin, Trinity College	Phase 3
Completed	Neuroinflammation in COVID-19 and Depression NCT04854785	Centre for Addiction and Mental Health	—
Unknown	The Effects of Anger and Joy Expressions on Approach and Avoidance Behaviors in Healthy Volunteers NCT04899609	University Hospital, Montpellier	—
Recruiting	Reward Processing and Depressive Subtypes: Identifying Neural Biotypes NCT06080646	San Francisco Veterans Affairs Medical Center	—
Completed	Depression-Reduction by Accelerated Personalized NeuroModulation and Its Effects on Sleep NCT04832750	University of Oldenburg	—
Unknown	Assessement of Capacity to Consent NCT04740463	University Hospital, Montpellier	—
Recruiting	University of Iowa Interventional Psychiatry Service Patient Registry NCT04480918	Mark Niciu	—
Completed	Predict MDE Outcomes After MST NCT03841019	Shanghai Mental Health Center	N/A
Completed	Terrorist Attack - Continuity of Care NCT03770156	Assistance Publique - Hôpitaux de Paris	—
Completed	Depressive Symptoms and Subjective Stress in the Course of the Menstrual Cycle - an Ambulatory Assessment Stud NCT04086316	Freie Universität Berlin	—
Recruiting	Comparing Uni- and Bi-lateral TBS in Major Depression NCT04142996	The Royal Ottawa Mental Health Centre	N/A
Completed	Validation Study: Mobile DSST on Cognition in Adults With MDD NCT03999567	Brain and Cognition Discovery Foundation	N/A
Withdrawn	Glabellar Botulinum Toxin Injections for the Treatment of Geriatric Depression NCT03833063	Helse Stavanger HF	Phase 1
Completed	Stress Systems and Psychotherapy in Depression NCT03752853	Freie Universität Berlin	N/A
Completed	Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder NCT03716869	Milton S. Hershey Medical Center	N/A
Completed	A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episod NCT03692910	Biogen	Phase 2
Active Not Recruiting	Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder NCT03336918	Brigham and Women's Hospital	—
Completed	The Role of Expectations in the Pharmacological Treatment of Depression - An Experimental Investigation NCT03190772	Philipps University Marburg	N/A
Completed	Cognitive Behavioural Therapy for the Treatment of Late Life Depression NCT03735576	University of Cologne	N/A
Completed	Ketamine as an Adjunctive Therapy for Major Depression NCT03256162	St Patrick's Hospital, Ireland	Phase 1
Completed	Medibio DDA Confirmatory Performance Study NCT03529513	Medibio Limited	—
Unknown	Investigation of Antidepressant Efficacy of Oral Ketamine Treatment NCT02992496	Medical University of Vienna	Phase 2
Completed	ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) NCT03113968	Bo Hu	Phase 2 / Phase 3
Terminated	NeoSync TMS Treatment for Bipolar I Depression NCT02839798	Butler Hospital	Phase 2
Unknown	Neuroinflammation, Serotonin, Impulsivity and Suicide NCT02824081	University Hospital, Montpellier	N/A
Terminated	Pain Perception in Suicidal Behavior Vulnerability NCT02915679	University Hospital, Montpellier	N/A
Completed	Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN) NCT02051413	Institut National de la Santé Et de la Recherche Médicale, France	Phase 4
Completed	Retrospective Observational Study DIANA Study NCT01976793	AstraZeneca	—
Completed	Ketamine for Suicidality in Bipolar Depression NCT01944293	New York State Psychiatric Institute	Phase 1 / Phase 2
Terminated	MRS and Medication Response: A Pilot Study NCT03254342	Stanford University	—
Unknown	Computerized Cognitive Remediation for Geriatric Depression NCT01979289	Weill Medical College of Cornell University	N/A
Completed	Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adul NCT01869374	New York State Psychiatric Institute	Phase 1 / Phase 2
Terminated	Study of Functional Networks in Resting fMRI NCT03323073	Assistance Publique - Hôpitaux de Paris	N/A
Unknown	A Study of Ketamine as an Antidepressant NCT01441505	The University of New South Wales	Phase 2
Terminated	Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression NCT01099592	Centre hospitalier de l'Université de Montréal (CHUM)	Phase 4
Completed	Major Depression and Messenger RNAs NCT00998231	Assistance Publique Hopitaux De Marseille	N/A
Completed	N-3 Polyunsaturated Fatty Acids in the Prevention and Treatment for IFN-induced Depression NCT01620502	National Science and Technology Council, Taiwan	N/A
Completed	Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled NCT00852592	Northwestern University	Phase 3
Completed	Ketamine as an Anaesthetic Agent in Electroconvulsive Therapy (ECT) NCT00680433	Northside Clinic, Australia	Phase 4
Completed	Predictors of the Response and Relapse/Recurrence After ECT for Depressed Patients NCT02032576	Kaohsiung Kai-Suan Psychiatric Hospital	Phase 4
Completed	Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression NCT00237666	The Medical Research Network	Phase 4